Genetic alterations during treatment of oligometastatic colorectal cancer (GATTACA) - GATTACA

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 87 人开始时间: 2017年1月12日最近更新: 2024年8月19日

试验速览

暂无简介。

•1. histologically proven oligometastatic colorectal cancer
•(Oligometastatic disease status defined as involving up to 3 organ systems; up to 3 metastases per organ system)
•2. Any treatment line irrespective of previous chemotherapy lines
•3.Patient treatment recommendation confirmed by an institutional multidisciplinary tumor board (MDT)
•4.Metastases amenable to complete ablation/resection using different techniques (radiofrequency ablation, thermoablation, photon beam radiation, surgery, including minimal invasive resections)
•5.Age >18 Jahre
•6.Life expectancy > 12 months
•7. signed and dated consent form

•1. Patients with metastases involving more than 3 organ systems (e.g. liver, lung, bone and retroperitoneal compartment)
•2. Patients with peritoneal or pleural metastases
•3. Patient having undergone Whipple Operation
•4. Second carcinoma, except carcinoma in situ of the cervix or basal cell carcinoma.
•5. Pregnancy

发起方

Klinikum der Universität München, Campus Großhadern